JPS56118013A - Calcitonin pharmaceutical and its preparation - Google Patents
Calcitonin pharmaceutical and its preparationInfo
- Publication number
- JPS56118013A JPS56118013A JP2156780A JP2156780A JPS56118013A JP S56118013 A JPS56118013 A JP S56118013A JP 2156780 A JP2156780 A JP 2156780A JP 2156780 A JP2156780 A JP 2156780A JP S56118013 A JPS56118013 A JP S56118013A
- Authority
- JP
- Japan
- Prior art keywords
- calcitonin
- pharmaceutical
- amino acid
- acid derivative
- dispersing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PURPOSE:To obtain a calcitonin pharmaceutical easily administrable of the noninjection type, by dispersing calcitonin with an amino acid derivative in a suppository base. CONSTITUTION:A calcitonin pharmaceutical for rectal administration prepared by dispersing calcitonin and an amino acid derivative, e.g. sodium N-(1-methyl-2- ethoxycarbonyl-vinyl)-DL-phenylglycinate, in a suppository base, e.g. cacao butter, uniformly. The calcitonin is a single chain polypeptide hormone consisting of 32 amino acids secreted from the thyroid gland of mammals, and acts on the bone, intestinal tract or kidney to reduce the calcium or inorganic phosphorus in blood. Therefore, the pharmaceutical is effective against hypercalcemia, particularly senile osteoporosis, however, has been only used as an injection. The use of the calcitonin with the amino acid derivative in the suppository permits the good absorption by the rectum and facilitates the administration of the calcitonin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2156780A JPS56118013A (en) | 1980-02-25 | 1980-02-25 | Calcitonin pharmaceutical and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2156780A JPS56118013A (en) | 1980-02-25 | 1980-02-25 | Calcitonin pharmaceutical and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56118013A true JPS56118013A (en) | 1981-09-16 |
JPS6236497B2 JPS6236497B2 (en) | 1987-08-07 |
Family
ID=12058592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2156780A Granted JPS56118013A (en) | 1980-02-25 | 1980-02-25 | Calcitonin pharmaceutical and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56118013A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5750926A (en) * | 1980-09-14 | 1982-03-25 | Sawai Seiyaku Kk | Absorption accelerator, base material and pharmaceutical for rectal administration containing the same |
JPS5785321A (en) * | 1980-11-14 | 1982-05-28 | Kyoto Yakuhin Kogyo Kk | Agent for promoting absorption of acylamino acid, and drug base and preparation for rectal administration containing the same |
JPH02193925A (en) * | 1989-01-23 | 1990-07-31 | Kanebo Ltd | Vaginal sappository |
AT396424B (en) * | 1987-09-15 | 1993-09-27 | Sandoz Ag | CALCITON INSUPPOSITORIES |
-
1980
- 1980-02-25 JP JP2156780A patent/JPS56118013A/en active Granted
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5750926A (en) * | 1980-09-14 | 1982-03-25 | Sawai Seiyaku Kk | Absorption accelerator, base material and pharmaceutical for rectal administration containing the same |
JPS6344124B2 (en) * | 1980-09-14 | 1988-09-02 | Sawai Seiyaku Kk | |
JPS5785321A (en) * | 1980-11-14 | 1982-05-28 | Kyoto Yakuhin Kogyo Kk | Agent for promoting absorption of acylamino acid, and drug base and preparation for rectal administration containing the same |
AT396424B (en) * | 1987-09-15 | 1993-09-27 | Sandoz Ag | CALCITON INSUPPOSITORIES |
JPH02193925A (en) * | 1989-01-23 | 1990-07-31 | Kanebo Ltd | Vaginal sappository |
Also Published As
Publication number | Publication date |
---|---|
JPS6236497B2 (en) | 1987-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5530570A (en) | Boot for universal joint | |
DK373587A (en) | MIXTURE VALVE WITH VALVE PLATES EQUIPPED WITH AN APPARATUS MECHANISM OF THE STAINLESS PLATE TO PROVIDE A COMPRESSION FORCE | |
FI854227A0 (en) | Process for the preparation of polypeptides useful as analgesic agent | |
FR2509613B1 (en) | INSULIN-BASED MEDICINE FOR THE TREATMENT OF SUGAR DIABETES | |
DE3377063D1 (en) | Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them | |
JPS5746950A (en) | Peptide, manufacture of same and medicinal composition containing same | |
IT8349596A0 (en) | MEDICINAL PREPARATION FOR THE TREATMENT OF GASTRODUODENAL ULCER | |
JPS56118013A (en) | Calcitonin pharmaceutical and its preparation | |
JPS56122309A (en) | Calcitonin pharmaceutical for rectal administration | |
IL95412A0 (en) | Pharmaceutical compositions containing 5-methyl-isoxazole-4-carboxylic acid anilide derivatives and 2-hydroxy-ethylidene-cyano acetic acid anilide derivatives | |
FI883589A0 (en) | Process for the preparation of unsaturated amino acid compounds | |
NO178325C (en) | Process for the preparation of a t-PA injection preparation | |
OA07270A (en) | N- (vinblastinoyl-23) amino acid derivatives, their preparation and therapeutic application. | |
IT8222763A0 (en) | PROCEDURE FOR THE PREPARATION OF N-FORMYL-L-ASPARTIC ACID ANHYDRIDE. | |
ES2012578A6 (en) | TROMETHAMINE SALT OF 1-METHYL- beta -OXO- alpha -(PHENYLCARBAMOYL)-2-PYRROLEPROPIONITRILE | |
ES508652A0 (en) | "PROCEDURE FOR THE PREPARATION OF COMPOUNDS CONTAINING AMIDA GROUPS OF CARBOXYLIC ACID". | |
JPS5228946A (en) | Amino acid infusion | |
EP0310288A3 (en) | Improved ovulation treatment | |
AU613858B2 (en) | Method of regulating animal reproduction | |
DE2962429D1 (en) | A pharmaceutical composition comprising an amino acid for reducing blood serum prolactin levels | |
JPS56122310A (en) | Suppository | |
JPS53104714A (en) | Compound proteins having serum calcium decreasing, immunity promoting actions and their preparation | |
JPS5531040A (en) | Agent to promote absorption of drug through digestive tract | |
FR2597763B1 (en) | SYSTEM FOR PRODUCING A HOMOGENEOUS MIXTURE OF MATERIALS, PARTICULARLY RUBBER-BASED COMPRISING A CAVITY TRANSFER MIXER | |
DE3162674D1 (en) | A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it |